Novo Nordisk's pricing tactics inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price tag gouging, pointing out the stark contrast in between U.S. prices and people in Europe and copyright. Novo Nordisk A/S is actually a Danish